Marshall Juergens v. Xanodyne Pharmaceuticals, Inc., et al
| In re: DARVOCET, DARVON, AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION |
| MARSHALL JUERGENS |
| XANODYNE PHARMACEUTICALS, INC., ELI LILLY AND COMPANY, AAIPHARMA, INC., AAIPHARMA LLC, AAI DEVELOPMENT SERVICES, INC., NEOSAN PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS, USA, INC. and TEVA BIOPHARMACEUTICALS, INC. |
| 12-6396 |
| November 11, 2012 |
| U.S. Court of Appeals, Sixth Circuit |
| P.I.: Product Liability |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Marshall Juergens v. Xanodyne Pharmaceuticals, Inc.
|
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
